malignant tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Consent form signed by the legally authorized client of the patient; 2. Patients of both genders and ages; 3. Patients who are hospitalized in our hospital due to malignant tumors and whose clinicians judge that blood or body fluid testing is necessary to provide evidence for clinical disease diagnosis, evaluation and treatment;
Exclusion criteria
Exclusion criteria: 1. The subject expressly refuses to participate in the study; 2. Subjects deemed unsuitable for this study by the investigator;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| exosome; | — |
Countries
China
Contacts
The First Affiliated Hospital of Soochow University